about
Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1)Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorderPeptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles.HIV-1 Vaccine Trials: Evolving Concepts and DesignsHIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity.NK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaquesMajor histocompatibility complex genomics and human disease.Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic optionsMicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell countsHLA-C and HIV-1: friends or foes?Structural insights into activation of antiviral NK cell responsesPegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integrationThe same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system.Therapeutic vaccines against HIV infection.Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.Association of chemokine receptor gene variants with HIV-1 genotype predicted tropism.Inverse comorbidity: the power of paradox in the advancement of science.
P2860
Q21560946-AC782D79-4FEB-4445-89CF-73475BD6725BQ28943293-9DEDA6D5-7DA4-4BC7-9FFF-417258A07DAFQ30413358-4B78485D-FD48-4D05-BE1F-27CE0F059269Q30425520-B7353472-B7A4-4FFA-9753-61A3501B72F5Q30833678-A1A6F3BA-C9EC-4C4F-8B64-1AEC0C341376Q33851763-09CB8892-1004-42FD-9B60-483975E33A53Q34359146-B439432A-F7DE-46FE-9576-33BF102CE5D3Q34466498-7D358ADF-5D8F-4A89-8BDC-65A506AD1F7CQ34747583-37D21446-6242-4393-8F0A-2201E16E9A8AQ36066058-C9CFFFE7-E98A-493F-884E-4504583BA8F9Q36317668-5F1A545B-4741-4AEB-8601-030B339391D0Q36495526-DF6B70F3-9244-45B0-A37D-E74EF03D02A4Q37272153-C47B4CB9-2D40-4032-830A-9BA15850751EQ38013505-F5EC76BA-313F-4A0F-B120-FC4FBBA796D6Q38098176-625572B9-1168-48E7-9D2D-45951DB9F59BQ42218498-B7DC1D97-4035-46CE-A18B-1C994AEB3515Q55196315-F40561CE-0D7A-455B-A345-57F2B495A95E
P2860
description
article publié dans la revue scientifique Science
@fr
im Dezember 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Science
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2010
@uk
name
First-Class Control of HIV-1
@en
First-Class Control of HIV-1
@nl
type
label
First-Class Control of HIV-1
@en
First-Class Control of HIV-1
@nl
prefLabel
First-Class Control of HIV-1
@en
First-Class Control of HIV-1
@nl
P2860
P356
P1433
P1476
First-Class Control of HIV-1
@en
P2093
A. J. McMichael
P2860
P304
P356
10.1126/SCIENCE.1200035
P407
P50
P577
2010-12-09T00:00:00Z